Biotech Series B Investors & VC Firms

900 firms in this list, with a median first check of $550K. 188 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
LD LDV Partners	88🔒	Palo Alto	US	Pre-Seed–Late Stage	—	+ Add to CRM
SA Santen Pharmaceutical	88🔒	Osaka	JP	Series A–Series C	—	+ Add to CRM
WE Wellcome Trust	88🔒	London	GB	Seed–Late Stage	—	+ Add to CRM
3H 3H Health Investment	88🔒	Shanghai	CN	Series A–Late Stage	—	+ Add to CRM
AV Avlar BioVentures	88🔒	Madingley	GB	Series A–Growth	—	+ Add to CRM
BO Boehringer Ingelheim Venture Fund	88🔒	Ingelheim am Rhein	DE	Seed–Growth	$16.2M	+ Add to CRM
CA Candy Capital	88🔒	—	GB	Seed–Growth	—	+ Add to CRM
CA Capital Medica Ventures	88🔒	Tokyo	JP	Pre-Seed–Growth	—	+ Add to CRM
CA CAS Star	88🔒	Xi’an	CN	Pre-Seed–Growth	—	+ Add to CRM
CB CBC Group	88🔒	Singapore	SG	Seed–Late Stage	—	+ Add to CRM
EI EISAI	88🔒	—	JP	Seed–Growth	—	+ Add to CRM
EN Entrepreneurs Fund	88🔒	London	GB	Series A–Growth	—	+ Add to CRM
EQ EQT Fund Management S.à.r.l.	88🔒	—	NL	Seed–Growth	—	+ Add to CRM
FU Future Fund: Breakthrough	88🔒	—	GB	Series B–Growth	—	+ Add to CRM
HO Hong Kong X Technology Fund	88🔒	Hong Kong	HK	Seed–Growth	—	+ Add to CRM
HS HSBC Innovation Ventures	88🔒	London	GB	Seed–Growth	—	+ Add to CRM
HU Hunt BioVentures	88🔒	Dallas	US	Seed–Growth	—	+ Add to CRM
IN Innovate Calgary	88🔒	Calgary	CA	Pre-Seed–Growth	—	+ Add to CRM
IN Investissement Quebec	88🔒	Quebec City	CA	Seed–Growth	—	+ Add to CRM
IP IP Group	88🔒	London	GB	Seed–Late Stage	—	+ Add to CRM
LA Lake Bleu Capital	88🔒	Hong Kong	HK	Seed–Growth	—	+ Add to CRM
NO Northern Gritstone	88🔒	Manchester	GB	Seed–Growth	—	+ Add to CRM
PR Providence Investment Company Limited	88🔒	Germany	US	Seed–Growth	—	+ Add to CRM
PT PTV Healthcare Capital	88🔒	Singapore	SG	Series B–Late Stage	—	+ Add to CRM

Data sourced from public filings and firms' own websites — see our methodology.